Molecular mechanisms of natural killer cell regulation

Frontiers in Bioscience

Volumn 17, Issue 4, 2012, Pages 1418-1432

  Watzl, Carsten ^a,b   Urlaub, Doris ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

Innate immunity; Mathematical modeling; Natural killer cells; Review; Signal transduction; Systems biology

Indexed keywords

HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; REVIEW;

HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION;

EID: 84859256791     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3995     Document Type: Article

References (150)

1. R. Kiessling, E. Klein and H. Wigzell: "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol, 5, 112-7 (1975).
2. R. B. Herberman, M. E. Nunn and D. H. Lavrin: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer, 16, 216-29 (1975).
3. T. Walzer, S. Jaeger, J. Chaix and E. Vivier: Natural killer cells: from CD3(-)NKp46(+) to post-genomics metaanalyses. Curr Opin Immunol, 19, 365-72 (2007). (Pubitemid 46687010)
4. M. Terme, E. Ullrich, N. F. Delahaye, N. Chaput and L. Zitvogel: Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol, 9, 486-94 (2008). (Pubitemid 351560517)
5. H. G. Ljunggren and K. J. Malmberg: Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol, 7, 329-39 (2007).
6. K. Imai, S. Matsuyama, S. Miyake, K. Suga and K. Nakachi: Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet, 356, 1795-9 (2000).
7. S.-H. Lee and C. A. Biron: Here today-not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections. Eur. J. Immunol., 40, 923-32 (2010).
8. J. S. Orange: Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol, 6, 399-409 (2006). (Pubitemid 44714151)
9. B. A. Croy, M. J. van den Heuvel, A. M. Borzychowski and C. Tayade: Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones. Immunol Rev, 214, 161-85 (2006). (Pubitemid 44707910)
10. E. Vivier, E. Tomasello, M. Baratin, T. Walzer and S. Ugolini: Functions of natural killer cells. Nat Immunol, 9, 503-10 (2008). (Pubitemid 351560519)
11. M. Colonna: Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity, 31, 15-23 (2009).
12. M. Lucas, S. Schachterle, K. Oberle, P. Aichele and A. Diefenbach: Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity, 26, 503-17, (2007). (Pubitemid 46602996)
13. E. Mortier, R. Advincula, L. Kim, S. Chmura, J. Barrera, B. Reizis, B. A. Malynn and A. Ma: Macrophageand dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets. Immunity, 31, 811-22 (2009).
14. L. L. Lanier: Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol, 9, 495-502 (2008). (Pubitemid 351560518)
15. C. Watzl and E. O. Long: Signal transduction during activation and inhibition of natural killer cells. Curr Protoc Immunol, Chapter 11, Unit 11 9B (2010).
16. M. Champsaur and L. L. Lanier: Effect of NKG2D ligand expression on host immune responses. Immunol Rev, 235, 267-85 (2010).
17. C. S. Brandt, M. Baratin, E. C. Yi, J. Kennedy, Z. Gao, B. Fox, B. Haldeman, C. D. Ostrander, T. Kaifu, C. Chabannon, A. Moretta, R. West, W. Xu, E. Vivier and S. D. Levin: The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med, 206, 1495-503 (2009).
18. M. Claus, S. Meinke, R. Bhat and C. Watzl: Regulation of NK cell activity by 2B4, NTB-A and CRACC. Front Biosci, 13, 956-65 (2008). (Pubitemid 351594740)
19. C. Bottino, R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, M. Vitale, L. Moretta, M. Lopez and A. Moretta: Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med, 198, 557-67 (2003). (Pubitemid 37040390)
20. S. Welte, S. Kuttruff, I. Waldhauer and A. Steinle: Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol, 7, 1334-42 (2006). (Pubitemid 46111255)
21. J. Spreu, S. Kuttruff, V. Stejfova, K. M. Dennehy, B. Schittek and A. Steinle: Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes. Proc Natl Acad Sci U S A, 107, 5100-5 (2010).
22. A. Diefenbach, E. Tomasello, M. Lucas, A. M. Jamieson, J. K. Hsia, E. Vivier and D. H. Raulet: Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol, 3, 1142-9 (2002). (Pubitemid 35469698)
23. J. Wu, Y. Song, A. B. Bakker, S. Bauer, T. Spies, L. L. Lanier and J. H. Phillips: An activating immunoreceptor complex formed by NKG2D and DAP10. Science, 285, 730-2 (1999).
24. J. L. Upshaw, L. N. Arneson, R. A. Schoon, C. J. Dick, D. D. Billadeau and P. J. Leibson: NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat Immunol, 7, 524-32 (2006).
25. D. Garrity, M. E. Call, J. Feng and K. W. Wucherpfennig: The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. Proc Natl Acad Sci U S A, 102, 7641- 6 (2005). (Pubitemid 40741024)
26. P. Sinai, C. Nguyen, J. D. Schatzle and C. Wulfing: Transience in polarization of cytolytic effectors is required for efficient killing and controlled by Cdc42. Proc Natl Acad Sci U S A, 26, 11912-7 (2010).
27. D. D. Billadeau, K. M. Brumbaugh, C. J. Dick, R. A. Schoon, X. R. Bustelo and P. J. Leibson: The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J Exp Med, 188, 549-59 (1998). (Pubitemid 28369144)
28. R. Galandrini, G. Palmieri, M. Piccoli, L. Frati and A. Santoni: Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. J Immunol, 162, 3148-52 (1999). (Pubitemid 29313559)
29. M. Cella, K. Fujikawa, I. Tassi, S. Kim, K. Latinis, S. Nishi, W. Yokoyama, M. Colonna and W. Swat: Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J Exp Med, 200, 817-23 (2004). (Pubitemid 39299468)
30. D. B. Graham, M. Cella, E. Giurisato, K. Fujikawa, A. V. Miletic, T. Kloeppel, K. Brim, T. Takai, A. S. Shaw, M. Colonna and W. Swat: Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics. J Immunol, 177, 2349-55 (2006). (Pubitemid 44200995)
31. E. Giurisato, M. Cella, T. Takai, T. Kurosaki, Y. Feng, G. D. Longmore, M. Colonna and A. S. Shaw: Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse. Mol Cell Biol, 27, 8583-99 (2007).
32. D. D. Billadeau, J. L. Upshaw, R. A. Schoon, C. J. Dick and P. J. Leibson: NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat Immunol, 4, 557-64 (2003). (Pubitemid 36701339)
33. S. Chiesa, M. Mingueneau, N. Fuseri, B. Malissen, D. H. Raulet, M. Malissen, E. Vivier and E. Tomasello: Multiplicity and plasticity of natural killer cell signaling pathways. Blood, 107, 2364-72 (2006). (Pubitemid 43345556)
34. S. Zompi, J. A. Hamerman, K. Ogasawara, E. Schweighoffer, V. L. Tybulewicz, J. P. Di Santo, L. L. Lanier and F. Colucci: NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol, 4, 565-72 (2003). (Pubitemid 36701340)
35. J. Sayos, C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M. G. Roncarolo, H. Oettgen, J. E. De Vries, G. Aversa and C. Terhorst: The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the coreceptor SLAM. Nature, 395, 462-9 (1998). (Pubitemid 28462434)
36. P. Eissmann and C. Watzl: Molecular Analysis of NTBA Signaling: A Role for EAT-2 in NTB-A-Mediated Activation of Human NK Cells. J Immunol, 177, 3170-7 (2006). (Pubitemid 44277835)
37. P. Eissmann, L. Beauchamp, J. Wooters, J. C. Tilton, E. O. Long and C. Watzl: Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood, 105, 4722-4729 (2005). (Pubitemid 40807295)
38. R. Roncagalli, J. E. Taylor, S. Zhang, X. Shi, R. Chen, M. E. Cruz-Munoz, L. Yin, S. Latour and A. Veillette: Negative regulation of natural killer cell function by EAT- 2, a SAP-related adaptor. Nat Immunol, 6, 1002-1010 (2005). (Pubitemid 41486185)
39. L. Benoit, X. Wang, H. F. Pabst, J. Dutz and R. Tan: Defective NK cell activation in X-linked lymphoproliferative disease. J Immunol, 165, 3549-53 (2000). (Pubitemid 32057255)
40. H. Nakajima, M. Cella, A. Bouchon, H. L. Grierson, J. Lewis, C. S. Duckett, J. I. Cohen and M. Colonna: Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur J Immunol, 30, 3309-18 (2000).
41. S. Parolini, C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H. D. Ochs, H. Wolf, J. Y. Bonnefoy, R. Biassoni, L. Moretta, L. D. Notarangelo and A. Moretta: X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med, 192, 337-46 (2000). (Pubitemid 30629159)
42. S. G. Tangye, J. H. Phillips, L. L. Lanier and K. E. Nichols: Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J Immunol, 165, 2932-6 (2000).
43. C. Bottino, M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L. D. Notarangelo, L. Moretta and A. Moretta: NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in Xlinked lymphoproliferative disease. J Exp Med, 194, 235-46 (2001). (Pubitemid 32730798)
44. B. Chan, A. Lanyi, H. K. Song, J. Griesbach, M. Simarro-Grande, F. Poy, D. Howie, J. Sumegi, C. Terhorst and M. J. Eck: SAP couples Fyn to SLAM immune receptors. Nat Cell Biol, 5, 155-60 (2003). (Pubitemid 36204198)
45. S. Latour, R. Roncagalli, R. Chen, M. Bakinowski, X. Shi, P. L. Schwartzberg, D. Davidson and A. Veillette: Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat Cell Biol, 5, 149-54 (2003). (Pubitemid 36204197)
46. C. Bloch-Queyrat, M. C. Fondaneche, R. Chen, L. Yin, F. Relouzat, A. Veillette, A. Fischer and S. Latour: Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J Exp Med, 202, 181-92 (2005). (Pubitemid 41002920)
47. I. Saborit-Villarroya, J. M. Del Valle, X. Romero, E. Esplugues, P. Lauzurica, P. Engel and M. Martin: The Adaptor Protein 3BP2 Binds Human CD244 and Links this Receptor to Vav Signaling, ERK Activation, and NK Cell Killing. J Immunol, 175, 4226-4235 (2005). (Pubitemid 41361956)
48. I. Saborit-Villarroya, A. Martinez-Barriocanal, I. Oliver-Vila, P. Engel, J. Sayos and M. Martin: The adaptor 3BP2 activates CD244-mediated cytotoxicity in PKC- and SAP-dependent mechanisms. Mol Immunol, 45, 3446-53 (2008).
49. R. Chen, F. Relouzat, R. Roncagalli, A. Aoukaty, R. Tan, S. Latour and A. Veillette: Molecular dissection of 2B4 signaling: implications for signal transduction by SLAMrelated receptors. Mol Cell Biol, 24, 5144-56 (2004). (Pubitemid 38738152)
50. C. Watzl, C. C. Stebbins and E. O. Long: NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J Immunol, 165, 3545-8 (2000). (Pubitemid 32057254)
51. C. Bottino, R. Augugliaro, R. Castriconi, M. Nanni, R. Biassoni, L. Moretta and A. Moretta: Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur J Immunol, 30, 3718-22 (2000). (Pubitemid 32005246)
52. A. Bouchon, M. Cella, H. L. Grierson, J. I. Cohen and M. Colonna: Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J Immunol, 167, 5517-21 (2001). (Pubitemid 33069369)
53. M. E. Cruz-Munoz, Z. Dong, X. Shi, S. Zhang and A. Veillette: Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function. Nat Immunol, 10, 297-305 (2009).
54. Z. Dong, M.-E. Cruz-Munoz, M.-C. Zhong, R. Chen, S. Latour and A. Veillette: Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat Immunol, 10, 973-80 (2009).
55. N. G. Clarkson, S. J. Simmonds, M. J. Puklavec and M. H. Brown: Direct and indirect interactions of the cytoplasmic region of CD244 (2B4) in mice and humans with FYN kinase. J Biol Chem, 282, 25385-94 (2007). (Pubitemid 47372836)
56. N. Wang, S. Calpe, J. Westcott, W. Castro, C. Ma, P. Engel, J. D. Schatzle and C. Terhorst: Cutting edge: The adapters EAT-2A and -2B are positive regulators of CD244- and CD84-dependent NK cell functions in the C57BL/6 mouse. Journal of immunology, 185, 5683-7 (2010).
57. K. M. Lee, M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett and V. Kumar: 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med, 199, 1245-54 (2004). (Pubitemid 38620261)
58. L. K. Chlewicki, C. A. Velikovsky, V. Balakrishnan, R. A. Mariuzza and V. Kumar: Molecular basis of the dual functions of 2B4 (CD244). J Immunol, 180, 8159-67 (2008).
59. Y. T. Bryceson, M. E. March, D. F. Barber, H. G. Ljunggren and E. O. Long: Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med, 202, 1001-12 (2005). (Pubitemid 41396899)
60. Y. T. Bryceson, M. E. March, H.-G. Ljunggren and E. O. Long: Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood, 107, 159-66 (2006). (Pubitemid 43053538)
61. H. S. Kim, A. Das, C. C. Gross, Y. T. Bryceson and E. O. Long: Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity, 32, 175-86 (2010).
62. F. Colucci, E. Schweighoffer, E. Tomasello, M. Turner, J. R. Ortaldo, E. Vivier, V. L. Tybulewicz and J. P. Di Santo: Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat Immunol, 3, 288-94 (2002). (Pubitemid 34213431)
63. N. D. Huntington, Y. Xu, S. L. Nutt and D. M. Tarlinton: A requirement for CD45 distinguishes Ly49Dmediated cytokine and chemokine production from killing in primary natural killer cells. J Exp Med, 201, 1421-33 (2005). (Pubitemid 40664086)
64. D. G. Hesslein, R. Takaki, M. L. Hermiston, A. Weiss and L. L. Lanier: Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc Natl Acad Sci U S A, 103, 7012-7 (2006).
65. L. H. Mason, J. Willette-Brown, L. S. Taylor and D. W. McVicar: Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J Immunol, 176, 6615-23 (2006). (Pubitemid 43787844)
66. J. Regunathan, Y. Chen, S. Kutlesa, X. Dai, L. Bai, R. Wen, D. Wang and S. Malarkannan: Differential and nonredundant roles of phospholipase Cgamma2 and phospholipase Cgamma1 in the terminal maturation of NK cells. J Immunol, 177, 5365-76 (2006). (Pubitemid 44527609)
67. J. L. Upshaw, R. A. Schoon, C. J. Dick, D. D. Billadeau and P. J. Leibson: The isoforms of phospholipase C-gamma are differentially used by distinct human NK activating receptors. J Immunol, 175, 213-8 (2005). (Pubitemid 40884321)
68. I. Tassi, R. Presti, S. Kim, W. M. Yokoyama, S. Gilfillan and M. Colonna: Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol, 175, 749-54 (2005). (Pubitemid 41094955)
69. A. Caraux, N. Kim, S. E. Bell, S. Zompi, T. Ranson, S. Lesjean-Pottier, M. E. Garcia-Ojeda, M. Turner and F. Colucci: Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood, 107, 994-1002 (2006). (Pubitemid 43156297)
70. A. Maul-Pavicic, S. C. Chiang, A. Rensing-Ehl, B. Jessen, C. Fauriat, S. M. Wood, S. Sjoqvist, M. Hufnagel, I. Schulze, T. Bass, W. W. Schamel, S. Fuchs, H. Pircher, C. A. McCarl, K. Mikoshiba, K. Schwarz, S. Feske, Y. T. Bryceson and S. Ehl: ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc Natl Acad Sci U S A, 107, 3324-9 (2011).
71. K. Jiang, B. Zhong, D. L. Gilvary, B. C. Corliss, E. Hong-Geller, S. Wei and J. Y. Djeu: Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat Immunol, 1, 419-25 (2000).
72. C. Li, B. Ge, M. Nicotra, J. N. Stern, H. D. Kopcow, X. Chen and J. L. Strominger: JNK MAP kinase activation is required for MTOC and granule polarization in NKG2Dmediated NK cell cytotoxicity. Proc Natl Acad Sci U S A, 105, 3017-22 (2008). (Pubitemid 351723660)
73. J. S. Orange, N. Ramesh, E. Remold-O'Donnell, Y. Sasahara, L. Koopman, M. Byrne, F. A. Bonilla, F. S. Rosen, R. S. Geha and J. L. Strominger: Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A, 99, 11351-11356 (2002). (Pubitemid 34920929)
74. A. Gismondi, L. Cifaldi, C. Mazza, S. Giliani, S. Parolini, S. Morrone, J. Jacobelli, E. Bandiera, L. Notarangelo and A. Santoni: Impaired natural and CD16- mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood, 104, 436-443 (2004). (Pubitemid 38900026)
75. D. M. Davis, I. Chiu, M. Fassett, G. B. Cohen, O. Mandelboim and J. L. Strominger: The human natural killer cell immune synapse. Proc Natl Acad Sci USA, 96, 15062-7 (1999). (Pubitemid 30019765)
76. C. Watzl and E. O. Long: Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J Exp Med, 197, 77-85 (2003). (Pubitemid 36110259)
77. G. Chan, T. Hanke and K. D. Fischer: Vav-1 regulates NK T cell development and NK cell cytotoxicity. Eur J Immunol, 31, 2403-10 (2001). (Pubitemid 32785359)
78. F. Colucci, E. Rosmaraki, S. Bregenholt, S. I. Samson, V. Di Bartolo, M. Turner, L. Vanes, V. Tybulewicz and J. P. Di Santo: Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms. J Exp Med, 193, 1413-24 (2001). (Pubitemid 32565970)
79. B. Riteau, D. F. Barber and E. O. Long: Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med, 198, 469-74 (2003). (Pubitemid 36976057)
80. J. Endt, F. E. McCann, C. R. Almeida, D. Urlaub, R. Leung, D. Pende, D. M. Davis and C. Watzl: Inhibitory Receptor Signals Suppress Ligation-Induced Recruitment of NKG2D to GM1-Rich Membrane Domains at the Human NK Cell Immune Synapse. J Immunol, 178, 5606- 11 (2007). (Pubitemid 46674356)
81. M. S. Fassett, D. M. Davis, M. M. Valter, G. B. Cohen and J. L. Strominger: Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc Natl Acad Sci U S A, 98, 14547-52 (2001). (Pubitemid 33121429)
82. Z. Lou, D. Jevremovic, D. D. Billadeau and P. J. Leibson: A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J Exp Med, 191, 347-54 (2000). (Pubitemid 30060923)
83. D. Lingwood and K. Simons: Lipid rafts as a membrane-organizing principle. Science, 327, 46-50 (2010).
84. A. M. Shenoy-Scaria, L. K. Gauen, J. Kwong, A. S. Shaw and D. M. Lublin: Palmitylation of an aminoterminal cysteine motif of protein tyrosine kinases p56lck and p59fyn mediates interaction with glycosylphosphatidylinositol- anchored proteins. Mol Cell Biol, 13, 6385-92 (1993). (Pubitemid 23292632)
85. K. Karre, H. G. Ljunggren, G. Piontek and R. Kiessling: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature, 319, 675-8 (1986). (Pubitemid 16119452)
86. K. Kärre: Natural killer cell recognition of missing self. Nat Immunol, 9, 477-80 (2008). (Pubitemid 351560515)
87. F. M. Karlhofer, R. K. Ribaudo and W. M. Yokoyama: MHC class I alloantigen specificity of Ly-49+ IL-2- activated natural killer cells. Nature, 358, 66-70 (1992).
88. K. A. Daniels, G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett and R. M. Welsh: Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med, 194, 29- 44 (2001). (Pubitemid 32660435)
89. S. H. Lee, S. Girard, D. Macina, M. Busà, A. Zafer, A. Belouchi, P. Gros and S. M. Vidal: Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet, 28, 42-5 (2001). (Pubitemid 32405814)
90. N. Wagtmann, R. Biassoni, C. Cantoni, S. Verdiani, M. S. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta and E. O. Long: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity, 2, 439-49 (1995).
91. E. O. Long: Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev, 224, 70-84 (2008).
92. S. Rajagopalan and E. O. Long: The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med, 185, 1523-8 (1997). (Pubitemid 27187611)
93. L. Fadda, G. Borhis, P. Ahmed, K. Cheent, S. V. Pageon, A. Cazaly, S. Stathopoulos, D. Middleton, A. Mulder, F. H. J. Claas, T. Elliott, D. M. Davis, M. A. Purbhoo and S. I. Khakoo: Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci USA, 107, 10160-5 (2010).
94. F. Borrego, M. Ulbrecht, E. H. Weiss, J. E. Coligan and A. G. Brooks: Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med, 187, 813-8 (1998). (Pubitemid 28115198)
95. R. E. Vance, J. R. Kraft, J. D. Altman, P. E. Jensen and D. H. Raulet: Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med, 188, 1841-8 (1998). (Pubitemid 28536771)
96. M. Colonna, F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella and M. Lopez-Botet: A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med, 186, 1809-18 (1997). (Pubitemid 27524591)
97. T. Avril, H. Floyd, F. Lopez, E. Vivier and P. R. Crocker: The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. J Immunol, 173, 6841-9 (2004). (Pubitemid 39541070)
98. P. R. Crocker, J. C. Paulson and A. Varki: Siglecs and their roles in the immune system. Nat Rev Immunol, 7, 255- 66 (2007). (Pubitemid 46480955)
99. R. J. Lebbink, T. de Ruiter, J. Adelmeijer, A. B. Brenkman, J. M. van Helvoort, M. Koch, R. W. Farndale, T. Lisman, A. Sonnenberg, P. J. Lenting and L. Meyaard: Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med, 203, 1419-25 (2006). (Pubitemid 43877604)
100. C. Gründemann, M. Bauer, O. Schweier, N. von Oppen, U. Lässing, P. Saudan, K.-F. Becker, K. Karp, T. Hanke, M. F. Bachmann and H. Pircher: Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J Immunol, 176, 1311-5 (2006). (Pubitemid 43134270)
101. M. Ito, T. Maruyama, N. Saito, S. Koganei, K. Yamamoto and N. Matsumoto: Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med, 203, 289-95 (2006). (Pubitemid 43290837)
102. G. Markel, N. Lieberman, G. Katz, T. I. Arnon, M. Lotem, O. Drize, R. S. Blumberg, E. Bar-Haim, R. Mader, L. Eisenbach and O. Mandelboim: CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol, 168, 2803-10 (2002). (Pubitemid 34211659)
103. D. D. Mousseau, D. Banville, D. L'Abbe, P. Bouchard and S. H. Shen: PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta. J Biol Chem, 275, 4467-74 (2000). (Pubitemid 30094691)
104. I. Shiratori, K. Ogasawara, T. Saito, L. L. Lanier and H. Arase: Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J Exp Med, 199, 525-33 (2004). (Pubitemid 38233836)
105. C. Cantoni, C. Bottino, R. Augugliaro, L. Morelli, E. Marcenaro, R. Castriconi, M. Vitale, D. Pende, S. Sivori, R. Millo, R. Biassoni, L. Moretta and A. Moretta: Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol, 29, 3148-59 (1999). (Pubitemid 29484205)
106. H. Aldemir, V. Prod'homme, M.-J. Dumaurier, C. Retiere, G. Poupon, J. Cazareth, F. Bihl and V. M. Braud: Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol, 175, 7791-5 (2005). (Pubitemid 41798337)
107. D. B. Rosen, J. Bettadapura, M. Alsharifi, P. A. Mathew, H. S. Warren and L. L. Lanier: Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol, 175, 7796-9 (2005). (Pubitemid 41798338)
108. M. Faure, D. F. Barber, S. M. Takahashi, T. Jin and E. O. Long: Spontaneous clustering and tyrosine phosphorylation of NK cell inhibitory receptor induced by ligand binding. J Immunol, 170, 6107-14 (2003). (Pubitemid 36682593)
109. D. N. Burshtyn, A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet and E. O. Long: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity, 4, 77-85 (1996). (Pubitemid 26056459)
110. L. Olcese, P. Lang, F. Vely, A. Cambiaggi, D. Marguet, M. Blery, K. L. Hippen, R. Biassoni, A. Moretta, L. Moretta, J. C. Cambier and E. Vivier: Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol, 156, 4531-4 (1996). (Pubitemid 26174429)
111. P. Hof, S. Pluskey, S. Dhe-Paganon, M. J. Eck and S. E. Shoelson: Crystal structure of the tyrosine phosphatase SHP-2. Cell, 92, 441-50 (1998). (Pubitemid 28101108)
112. W. Lu, D. Gong, D. Bar-Sagi and P. A. Cole: Sitespecific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell, 8, 759-69 (2001). (Pubitemid 33030210)
113. M.-C. Yu, L.-L. Su, L. Zou, Y. Liu, N. Wu, L. Kong, Z.-H. Zhuang, L. Sun, H.-P. Liu, J.-H. Hu, D. Li, J. L. Strominger, J.-W. Zang, G. Pei and B.-X. Ge: An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. Nat Immunol, 9, 898-907 (2008).
114. A. Verbrugge, E. S. Rijkers, T. de Ruiter and L. Meyaard: Leukocyte-associated Ig-like receptor-1 has SH2 domain-containing phosphatase-independent function and recruits C-terminal Src kinase. Eur J Immunol, 36, 190-8 (2006). (Pubitemid 43116405)
115. C. C. Stebbins, C. Watzl, D. D. Billadeau, P. J. Leibson, D. N. Burshtyn and E. O. Long: Vav1 Dephosphorylation by the Tyrosine Phosphatase SHP-1 as a Mechanism for Inhibition of Cellular Cytotoxicity. Mol Cell Biol, 23, 6291-6299 (2003). (Pubitemid 37013105)
116. M. E. Peterson and E. O. Long: Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity, 29, 578-88 (2008).
117. S. Andersson, C. Fauriat, J.-A. Malmberg, H.-G. Ljunggren and K.-J. Malmberg: KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood, 114, 95- 104 (2009).
118. A. Saleh, G. E. Davies, V. Pascal, P. W. Wright, D. L. Hodge, E. H. Cho, S. J. Lockett, M. Abshari and S. K. Anderson: Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity, 21, 55-66 (2004). (Pubitemid 38925267)
119. W. Held, J. R. Dorfman, M. F. Wu and D. H. Raulet: Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur J Immunol, 26, 2286-92 (1996). (Pubitemid 26340925)
120. N. M. Valiante, M. Uhrberg, H. G. Shilling, K. Lienert-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier and P. Parham: Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity, 7, 739-51 (1997). (Pubitemid 28064888)
121. M. Bix, N. S. Liao, M. Zijlstra, J. Loring, R. Jaenisch and D. Raulet: Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature, 349, 329-31 (1991). (Pubitemid 21912075)
122. P. Hoglund, C. Ohlen, E. Carbone, L. Franksson, H. G. Ljunggren, A. Latour, B. Koller and K. Karre: Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc Natl Acad Sci U S A, 88, 10332-6 (1991). (Pubitemid 21915829)
123. N. Anfossi, P. Andre, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, F. Romagne, S. Ugolini and E. Vivier: Human NK cell education by inhibitory receptors for MHC class I. Immunity, 25, 331-42 (2006). (Pubitemid 44224147)
124. N. C. Fernandez, E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux and D. H. Raulet: A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood, 105, 4416-23 (2005). (Pubitemid 40720789)
125. S. Kim, J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen and W. M. Yokoyama: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature, 436, 709-13 (2005). (Pubitemid 41117274)
126. W. M. Yokoyama and S. Kim: How do natural killer cells find self to achieve tolerance? Immunity, 24, 249-57 (2006).
127. D. H. Raulet and R. E. Vance: Self-tolerance of natural killer cells. Nat Rev Immunol, 6, 520-31 (2006). (Pubitemid 43980524)
128. P. Brodin, T. Lakshmikanth, S. Johansson, K. Kärre and P. Höglund: The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood, 113, 2434-41 (2009).
129. P. Brodin, K. Kärre and P. Höglund: NK cell education: not an on-off switch but a tunable rheostat. Trends in Immunology, 30, 143-9 (2009).
130. A. Chalifour, L. Scarpellino, J. Back, P. Brodin, E. Devèvre, F. Gros, F. Lévy, G. Leclercq, P. Höglund, F. Beermann and W. Held: A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity, 30, 337-47 (2009).
131. N. T. Joncker, N. Shifrin, F. Delebecque and D. H. Raulet: Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med, 10, 2065-72 (2010).
132. J. M. Elliott, J. A. Wahle and W. M. Yokoyama: MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med, 10, 2073-9 (2010).
133. D. N. Burshtyn, J. Shin, C. Stebbins and E. O. Long: Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr Biol, 10, 777-80 (2000). (Pubitemid 30466940)
134. Y. T. Bryceson, H. G. Ljunggren and E. O. Long: Minimal requirement for
135. F. E. McCann, B. Vanherberghen, K. Eleme, L. M. Carlin, R. J. Newsam, D. Goulding and D. M. Davis: The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses. J Immunol, 170, 2862-70 (2003). (Pubitemid 36302156)
136. E. O. Long, D. F. Barber, D. N. Burshtyn, M. Faure, M. Peterson, S. Rajagopalan, V. Renard, M. Sandusky, C. C. Stebbins, N. Wagtmann and C. Watzl: Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol Rev, 181, 223-33 (2001). (Pubitemid 32703410)
137. M. Eriksson, G. Leitz, E. Fallman, O. Axner, J. C. Ryan, M. C. Nakamura and C. L. Sentman: Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. J Exp Med, 190, 1005-12 (1999). (Pubitemid 29480829)
138. A. Das and E. O. Long: Lytic Granule Polarization, Rather than Degranulation, Is the Preferred Target of Inhibitory Receptors in NK Cells. J Immunol (2010).
139. K. Ramirez and B. L. Kee: Multiple hats for natural killers. Curr Opin Immunol, 22, 193-8 (2010).
140. J. P. Di Santo: Natural killer cells: diversity in search of a niche. Nat Immunol, 9, 473-5 (2008).
141. J. Das: Activation or tolerance of natural killer cells is modulated by ligand quality in a nonmonotonic manner. Biophys J, 99, 2028-37 (2010).
142. G. Altan-Bonnet and R. N. Germain: Modeling T cell antigen discrimination based on feedback control of digital ERK responses. PLoS Biol, 3, e356 (2005).
143. L. Kuepfer, M. Peter, U. Sauer and J. Stelling: Ensemble modeling for analysis of cell signaling dynamics. Nat Biotechnol, 25, 1001-6 (2007). (Pubitemid 47517639)
144. S. Mesecke, D. Urlaub, H. Busch, R. Eils and C. Watzl: Integration of activating and inhibitory immunereceptor signaling by regulated Vav1 phosphorylation. Science Signaling, 4, ra36 (2011).
145. P. Hoglund, H. G. Ljunggren, C. Ohlen, L. Ahrlund- Richter, G. Scangos, C. Bieberich, G. Jay, G. Klein and K. Karre: Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice. J Exp Med, 168, 1469-74 (1988). (Pubitemid 18264878)
146. C. Ohlen, G. Kling, P. Hoglund, M. Hansson, G. Scangos, C. Bieberich, G. Jay and K. Karre: Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science, 246, 666-8 (1989). (Pubitemid 19283359)
147. D. H. Raulet, W. Held, I. Correa, J. R. Dorfman, M. F. Wu and L. Corral: Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunological reviews, 155, 41-52 (1997). (Pubitemid 27076057)
148. S. Johansson, M. Johansson, E. Rosmaraki, G. Vahlne, R. Mehr, M. Salmon-Divon, F. Lemonnier, K. Karre and P. Hoglund: Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med, 201, 1145-55 (2005). (Pubitemid 40524682)
149. S. Johansson, M. Salmon-Divon, M. H. Johansson, Y. Pickman, P. Brodin, K. Kärre, R. Mehr and P. Höglund: Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice. PLoS ONE, 4, e6046 (2009).
150. J. C. Sun, J. N. Beilke and L. L. Lanier: Immune memory redefined: characterizing the longevity of natural killer cells. Immunological reviews, 236, 83-94 (2010).